Align Technology (ALGN) to Announce Earnings on Wednesday

Align Technology (NASDAQ:ALGN) is expected to post its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect the company to announce earnings of $2.62 per share and revenue of $1.0519 billion for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 4:30 PM ET.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $2.26 by $0.32. Align Technology had a return on equity of 15.82% and a net margin of 10.50%.The firm had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the prior year, the business posted $2.13 EPS. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. On average, analysts expect Align Technology to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

Align Technology Price Performance

ALGN opened at $167.01 on Monday. The business’s 50-day moving average is $173.31 and its two-hundred day moving average is $175.11. Align Technology has a 1 year low of $122.00 and a 1 year high of $208.30. The firm has a market capitalization of $11.96 billion, a PE ratio of 28.02, a price-to-earnings-growth ratio of 1.71 and a beta of 1.67.

Align Technology declared that its Board of Directors has approved a share buyback program on Wednesday, April 29th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the medical equipment provider to purchase up to 1.6% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Evercore raised their price target on shares of Align Technology from $200.00 to $220.00 in a report on Thursday, April 30th. Citigroup initiated coverage on shares of Align Technology in a research note on Wednesday, April 15th. They set a “buy” rating and a $240.00 price objective for the company. Wall Street Zen raised shares of Align Technology from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. Weiss Ratings raised shares of Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Finally, Leerink Partners lifted their price target on shares of Align Technology from $225.00 to $230.00 in a report on Thursday, April 30th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Align Technology currently has an average rating of “Moderate Buy” and an average target price of $206.36.

Hedge Funds Weigh In On Align Technology

Hedge funds have recently modified their holdings of the stock. Sunbelt Securities Inc. raised its position in shares of Align Technology by 222.4% in the 4th quarter. Sunbelt Securities Inc. now owns 158 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 109 shares during the last quarter. CYBER HORNET ETFs LLC purchased a new stake in Align Technology during the 2nd quarter worth approximately $36,000. MUFG Securities EMEA plc purchased a new stake in Align Technology during the 2nd quarter worth approximately $38,000. Global Retirement Partners LLC increased its stake in Align Technology by 101.8% during the 4th quarter. Global Retirement Partners LLC now owns 230 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 116 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its stake in Align Technology by 1,773.3% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 281 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 266 shares in the last quarter. Institutional investors and hedge funds own 88.43% of the company’s stock.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.